Co-occurring Melanoma in an Active Area of Vitiligo in Skin of Color
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patient with vitiligo, is thought to be decreased. This report presents a case of melanoma developing on a non-sun-exposed site in a patient with …
Continue reading “Co-occurring Melanoma in an Active Area of Vitiligo in Skin of Color”
JDD January 2025 Editor’s Picks | Special Focus: Aesthetic Treatments
Welcome to the first issue of the Journal of Drugs in Dermatology for 2025! This issues focuses on the exciting advancements in aesthetic treatments, with editor’s picks that delve into cutting-edge topics shaping dermatology today. From the role of exosomes in cosmetic dermatology to expert insights on managing neuromodulator complications, this issue offers invaluable guidance …
Continue reading “JDD January 2025 Editor’s Picks | Special Focus: Aesthetic Treatments”
JDD Buzz Series | Metformin’s Potential Chemopreventive Effect
A commonly used diabetes medication may help prevent non-melanoma skin cancer. A study in the December Journal of Drugs in Dermatology analyzed whether metformin exposure is associated with a reduced risk of non-melanoma skin cancer. The study also stratified findings by race/ethnicity, which makes it unique among similar research studies. I interviewed author Tiffany Jow …
Continue reading “JDD Buzz Series | Metformin’s Potential Chemopreventive Effect”
Hyperpigmented Macules and Patches on the Face: Exogenous Ochronosis or Lichen Planus Pigmentosus?
JDD authors Deepika Narayanan, MD and Stephen K. Tyring, MD, PhD, MBA present a case of a patient with a 10-year history of blue-black macules and patches on the face and an associated history of skin- lightening cream usage. The skin lightening cream contained hydroquinone, which is often associated with exogenous ochronosis (EO). Interestingly, the …
JDD December Editor’s Picks: A Spotlight on Dermatology’s Latest Innovations
As 2024 comes to a close, the Journal of Drugs in Dermatology delivers a stellar lineup of research, reviews, and insights to inform your practice and inspire your curiosity. This month’s Editor’s Picks feature cutting-edge studies and expert commentary on a range of topics, from advanced acne treatments to groundbreaking leadership initiatives in dermatology. Laser …
Continue reading “JDD December Editor’s Picks: A Spotlight on Dermatology’s Latest Innovations”
JDD Buzz Series | AI Chatbots in Dermatology
Are AI chatbots a wave of the future in dermatology? An article in the November Journal of Drugs in Dermatology assessed dermatologists’ attitudes and beliefs toward artificial intelligence chatbots. Chatbot usage has grown in a variety of areas of society in recent years, and ChatGPT’s popularity shows there’s demand. So to what extent do dermatologists …
Continue reading “JDD Buzz Series | AI Chatbots in Dermatology”
JDD November 2024 Issue Highlights | Special Focus: Lasers, Light Sources, and Devices
The November Journal of Drugs in Dermatology Editor’s Picks spotlight the dynamic intersection of Lasers, Light Sources, and Devices in dermatology, featuring a mix of insightful studies and discussions. This month’s selections include an intriguing national survey capturing over 190 dermatologists’ perspectives on the role of AI chatbots in dermatology, examining the potential applications, benefits, …
Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population
INTRODUCTION Melanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas but is associated with poorer prognosis.2 Patients of color are disproportionately affected by AMM. Elucidating the clinical, genetic, and environmental features of AMM can guide advancements …
Continue reading “Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population”
JDD October 2024 Issue Highlights | Special Focus: Atopic Dermatitis
October’s Journal of Drugs in Dermatology Editor’s Picks offer an exciting look into cutting-edge research, with a special focus on atopic dermatitis and several related skin conditions. This month’s selections dive deep into groundbreaking studies, ranging from innovative treatments for acne and environmental skin aging to advancements in hyperhidrosis research using machine learning models. Notably, …
Continue reading “JDD October 2024 Issue Highlights | Special Focus: Atopic Dermatitis”
JDD Buzz Series | Algorithmic Beauty
A study in the September Journal of Drugs in Dermatology addressed the impact of social media algorithms on the perception of beauty. While the golden ratio dates back to ancient Greece – and is an ages-old beauty standard for those of European ancestry – beauty ideals of facial features often change over time and vary …